New York Life Investment Management’s Chemed CHE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$641K Buy
1,697
+395
+30% +$169K 0.01% 735
2025
Q4
$557K Sell
1,302
-165
-11% -$71.8K ﹤0.01% 710
2025
Q3
$657K Sell
1,467
-46
-3% -$20.8K 0.01% 732
2025
Q2
$737K Sell
1,513
-64
-4% -$36.5K 0.01% 701
2025
Q1
$970K Buy
1,577
+18
+1% +$10.2K 0.01% 651
2024
Q4
$826K Sell
1,559
-144
-8% -$81.2K 0.01% 701
2024
Q3
$1.02M Buy
+1,703
New +$965K 0.01% 695
2024
Q2
Sell
-1,629
Closed -$1.05M 946
2024
Q1
$1.05M Sell
1,629
-35
-2% -$21.3K 0.01% 662
2023
Q4
$973K Buy
+1,664
New +$931K 0.01% 663

Other funds holding CHE

New York Life Investment Management's CHE Position: Q1 2026 in Review

New York Life Investment Management increased its Chemed (CHE) stake by 30% in Q1 2026, buying an estimated $169K and bringing the position to 1,697 shares worth $641K. The position accounts for 0.01% of the portfolio, ranked #735.

New York Life Investment Management first reported a position in CHE in Q4 2023 and has held it in 9 quarters since. The position peaked at $1.05M in Q1 2024. 490 funds tracked by Wall St. Rank hold CHE as of Q1 2026.

  • New York Life Investment Management held 1,697 shares of Chemed worth $641K as of Q1 2026.
  • New York Life Investment Management bought 395 Chemed shares in Q1 2026, an estimated $169K.
  • Chemed made up 0.01% of New York Life Investment Management's portfolio in Q1 2026, its #735 holding.
  • New York Life Investment Management first reported a position in Chemed in Q4 2023 and has held it in 9 quarters since.
  • New York Life Investment Management's Chemed position peaked at $1.05M in Q1 2024.
  • 490 funds tracked by Wall St. Rank held Chemed as of Q1 2026.

Based on New York Life Investment Management's 13F filing for Q1 2026, filed 7 May 2026.